Home/Filings/4/0001140361-20-026646
4//SEC Filing

Sooch Mina 4

Accession 0001140361-20-026646

CIK 0001228627other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 7:26 PM ET

Size

8.9 KB

Accession

0001140361-20-026646

Insider Transaction Report

Form 4
Period: 2020-11-19
Sooch Mina
DirectorPresident and CEO
Transactions
  • Purchase

    Series B Warrant (right to buy)

    2020-11-19+2,0462,046 total
    Exercise: $0.00From: 2020-11-19Exp: 2022-01-28Common Stock (2,046 underlying)
  • Purchase

    Common Stock

    2020-11-19+11,524800,044 total
  • Purchase

    Series A Warrant (right to buy)

    2020-11-19+17,41317,413 total
    Exercise: $4.48From: 2020-11-19Exp: 2025-11-19Common Stock (17,413 underlying)
Footnotes (2)
  • [F1]The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $65,000.
  • [F2]Subject to adjustment based on certain price reset provisions.

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001674006

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 7:26 PM ET
Size
8.9 KB